AntineoplasticsTreatment-related myelodysplastic syndrome, pure red cell aplasia and pancytopenia: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1760卷 / 1期

关键词：

D O I：

10.1007/s40278-019-64192-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：33 / 33

相关论文

共 50 条

[1] AntineoplasticsTreatment-related death: case report
[J]. Reactions Weekly, 2020, 1798 (1) : 39 - 39
[2] AntineoplasticsTreatment-related mortality: case report
[J]. Reactions Weekly, 2017, 1667 (1) : 36 - 36
[3] AntineoplasticsTreatment-related death: case report
[J]. Reactions Weekly, 2020, 1825 (1) : 40 - 40
[4] AntineoplasticsTreatment-related mortality: case report
[J]. Reactions Weekly, 2019, 1754 (1) : 47 - 47
[5] AntineoplasticsTreatment-related acute myeloid leukaemia: case report
[J]. Reactions Weekly, 2022, 1925 (1) : 73 - 73
[6] AntineoplasticsMyelodysplastic syndrome and pure red cell aplasia: case report
[J]. Reactions Weekly, 2019, 1770 (1) : 45 - 45
[7] Myelodysplastic syndrome with erythroid aplasia following pure red cell aplasia.
Kim, KW
Kim, HJ
Park, SY
[J]. BLOOD, 2002, 100 (11) : 339B - 339B
[8] Myelodysplastic pure red cell aplasia
Xu, Zhaodong
Mueller, Rosemary
[J]. BLOOD, 2021, 138 (06) : 500 - 500
[9] Pure red cell aplasia with myelodysplastic changes
Schilling, VR
Herola, AG
Fernández, CS
Parreño, LD
[J]. REVISTA CLINICA ESPANOLA, 2002, 202 (03): : 182 - 183
[10] ClozapineFirst report of pure red cell aplasia: case report
[J]. Reactions Weekly, 2015, 1549 (1) : 75 - 75

← 1 2 3 4 5 →